跳至主要内容
临床试验/ISRCTN15032219
ISRCTN15032219已完成不适用

Effects of multispecies probiotic supplementation on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

Farcoderm S.R.L.0 个研究点目标入组 150 人开始时间: 2016年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged between 18 and 65 years old
  • 2. Suffering from Irritable Bowel Syndrome with constipation (IBS-C)

排除标准

  • 1. Pregnancy or intention to become pregnant during the study period
  • 2. Lactation
  • 3. Food intolerances/allergy
  • 4. Known history of gastro-intestinal disorders
  • 5. Chronic or acute gastrointestinal disorders
  • 6. Participation in another similar study
  • 7. Unwillingness or inability to comply with the study protocol requirements
  • 8. Currently using food supplements or drugs containing actives having an influence on gastro-intestinal physiology

研究者

发起方
Farcoderm S.R.L.

相似试验

Clinical study carried out to investigate the... | 临床试验